Bone morphogenetic protein receptor type-2
| GO Term | Evidence Code | Reference |
|---|---|---|
| mesoderm formation | ||
| cell fate specification | ||
| maternal placenta development | ||
| endothelial cell proliferation | ||
| endothelial cell proliferation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| nucleoplasm | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| protein serine/threonine kinase activity | ||
| protein serine/threonine kinase activity | ||
| transforming growth factor beta receptor activity | ||
| ATP binding | ||
| activin receptor activity, type II |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 55 |
|
|||
| 110 |
|
|
||
| 126 |
|
|
||
| 652 |
|
|
||
| 805 |
|
|||
| 822 |
|
| Pathway Name | Organism |
|---|---|
| Signaling by BMP | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:14557 | primary pulmonary hypertension |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026